Lin Peng, Pang Jin-Shu, Lin Ya-Dan, Qin Qiong, Lv Jia-Yi, Zhou Gui-Qian, Tan Tian-Ming, Mo Wei-Jia, Chen Gang
Department of Medical Ultrasound, Fujian Medical University Union Hospital, Fuzhou, China.
Department of Medical Ultrasound, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Insights Imaging. 2025 Feb 17;16(1):42. doi: 10.1186/s13244-025-01900-2.
To evaluate the ability of sphericity in glioblastomas (GBMs) for predicting overall survival (OS) and the survival benefit from gross tumour resection (GTR).
Preoperative MRI scans were retrospectively analysed in IDH-wildtype GBM patients from two datasets. After MRI preprocessing and tumour segmentation, tumour sphericity was calculated based on the tumour core region. The prognostic value of tumour surface regularity was evaluated via Kaplan-Meier (K-M) plots, univariate and multivariate Cox proportional hazards analyses. In different surface regularity subgroups, the OS benefit from GTR was evaluated via K-M plots and the restricted mean survival time (RMST).
This study included 367 patients (median age, 62.0 years [IQR, 54.5-70.5 years]) in the discovery cohort and 475 patients (median age, 63.6 years [IQR, 56.2-71.3 years]) in the validation cohort. Sphericity was an independent predictor of OS in the discovery (p = 0.022, hazard ratio (HR) = 1.45, 95% confidence interval (CI) 1.06-1.99) and validation groups (p = 0.007, HR = 1.38, 95% CI: 1.09-1.74) according to multivariate analysis. Age, extent of resection, and surface regularity composed a prognostic model that separated patients into subgroups with distinct prognoses. Patients in the surface-irregular subgroup benefited from GTR, but patients in the surface-regular subgroup did not in the discovery (p < 0.001 vs. p = 0.056) and validation datasets (p < 0.001 vs. p = 0.11).
The high surface regularity of IDH-wildtype GBM is significantly correlated with better OS and does not benefit substantially from GTR.
The proposed imaging marker has the potential to increase the survival prediction efficacy for IDH-wildtype glioblastomas (GBMs), offering a valuable indicator for clinical decision-making.
Sphericity is an independent prognostic factor in IDH-wildtype glioblastomas (GBMs). High sphericity in IDH-wildtype GBM is significantly correlated with better survival. GBM patients with low sphericity could receive survival benefits from gross tumour resection.
评估胶质母细胞瘤(GBM)的球形度预测总生存期(OS)以及从肿瘤全切除(GTR)中获得生存获益的能力。
对来自两个数据集的异柠檬酸脱氢酶(IDH)野生型GBM患者的术前磁共振成像(MRI)扫描进行回顾性分析。在MRI预处理和肿瘤分割后,基于肿瘤核心区域计算肿瘤球形度。通过Kaplan-Meier(K-M)曲线、单因素和多因素Cox比例风险分析评估肿瘤表面规则性的预后价值。在不同表面规则性子组中,通过K-M曲线和受限平均生存时间(RMST)评估GTR带来的OS获益。
本研究纳入了发现队列中的367例患者(中位年龄62.0岁[四分位间距,54.5 - 70.5岁])和验证队列中的475例患者(中位年龄63.6岁[四分位间距,56.2 - 71.3岁])。根据多因素分析,球形度在发现队列(p = 0.022,风险比[HR] = 1.45,95%置信区间[CI] 1.06 - 1.99)和验证队列(p = 0.007,HR = 1.38,95% CI:1.09 - 1.74)中是OS的独立预测因素。年龄、切除范围和表面规则性构成了一个预后模型,将患者分为具有不同预后的亚组。表面不规则亚组的患者从GTR中获益,但表面规则亚组的患者在发现队列(p < 0.001对p = 0.056)和验证数据集中(p < 0.001对p = 0.11)未获益。
IDH野生型GBM的高表面规则性与更好的OS显著相关,且从GTR中未获得实质性获益。
所提出的影像标志物有可能提高IDH野生型胶质母细胞瘤(GBM)的生存预测效能,为临床决策提供有价值的指标。
球形度是IDH野生型胶质母细胞瘤(GBM)的独立预后因素。IDH野生型GBM的高球形度与更好的生存显著相关。球形度低的GBM患者可从肿瘤全切除中获得生存获益。